<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recently, we identified in normally type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>-prone <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOD</z:e>/LtJ mice a spontaneous new leptin receptor (LEPR) mutation (designated Lepr(db-5J)) producing juvenile <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>, <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo>, and hyperleptinemia </plain></SENT>
<SENT sid="1" pm="."><plain>This early type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> syndrome suppressed intra-islet <z:mp ids='MP_0004031'>insulitis</z:mp> and permitted spontaneous <z:mp ids='MP_0002055'>diabetes</z:mp> remission </plain></SENT>
<SENT sid="2" pm="."><plain>No significant differences in plasma <z:chebi fb="0" ids="16827">corticosterone</z:chebi>, splenic CD4(+) or CD8(+) T-cell percentages, or functions of CD3(+) T-cells in vitro distinguished <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOD</z:e> <z:mp ids='MP_0002169'>wild-type</z:mp> from mutant mice </plain></SENT>
<SENT sid="3" pm="."><plain>Yet splenocytes from hyperglycemic mutant donors failed to transfer type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> into <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOD</z:e>.Rag1(-/-) recipients over a 13-week period, whereas <z:mp ids='MP_0002169'>wild-type</z:mp> donor cells did so </plain></SENT>
<SENT sid="4" pm="."><plain>This correlated with significantly reduced (P &lt; 0.01) frequencies of insulin and islet-specific <z:chebi fb="105" ids="17234">glucose</z:chebi>-6-phosphatase catalytic subunit-related protein-reactive CD8(+) T-effector clonotypes in mutant mice </plain></SENT>
<SENT sid="5" pm="."><plain>Intra-islet <z:mp ids='MP_0004031'>insulitis</z:mp> was also significantly suppressed in lethally irradiated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOD</z:e>-Lepr(db-5J)/Lt recipients reconstituted with <z:mp ids='MP_0002169'>wild-type</z:mp> bone marrow (P &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> eventually developed when mutant marrow was transplanted into irradiated <z:mp ids='MP_0002169'>wild-type</z:mp> recipients </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="52290">Mitogen</z:chebi>-induced T-cell blastogenesis was significantly suppressed when splenic T-cells from both <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOD</z:e>/Lt and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOD</z:e>-Lepr(db-5J)/Lt donors were incubated with irradiated mutant peritoneal exudate cells (P &lt; 0.005) </plain></SENT>
<SENT sid="8" pm="."><plain>In conclusion, metabolic disturbances elicited by a type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> syndrome (insulin and/or leptin resistance, but not <z:e sem="disease" ids="C0001622" disease_type="Disease or Syndrome" abbrv="">hypercorticism</z:e>) appear to suppress type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> development in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOD</z:e>-Lepr(db-5J)/Lt by inhibiting activation of T-effector cells </plain></SENT>
</text></document>